Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Trend Analysis of Lung Cancer Incidence Rates in Ninawa Province, Iraq, from 2000 to 2010 - Decrease and Recent Stability

  • Published : 2014.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Lung cancer is the most frequent malignancy of men worldwide. In Ninawa in Iraq, lung cancer ranks first among cancers diagnosed in men. Since no prior studies have been conducted on incidence trends in our population the present investigation of rates during 2000-2010 was therefore performed. Materials and Methods: Registy data for lung cancer cases were collected from the Directorate of Health in Ninawa-Mosul Continuing Medical Education Center. We restricted our analyses to men categorized according to the age groups of 0- 39, 40-49, 50-59, 60-69 and 70+ years. The significance of incidence rate trends during 2000-2010 was tested using Poisson regression. Age-standardized rates (ASR), and age-specific rates per 100,000 population were calculated. Results: A total of 1,206 incident lung cancer were registered among males, accounting for 15.5% of all male cancers registered during 2000-2010. It ranked first throughout the period. Median age at diagnosis was 69 (mean $66.8{\pm}11.0$) years. The incidence rate of all male lung cancers in Ninawa (all ages) decreased from 26.4 per 100,000 in 2000 to 12.7 in 2010 (APC=-6.55%, p<.0001). The incidences in age groups 40-49, 50-59, 60-69 and 70+ decreased in earlier years and recently appeared (2007-2010) stable. The incidence in age group (0-39) remained stable between 2000-2010. Squamous cell carcinoma (SCC)was the most common type of lung cancer, while adenocarcinoma was relatively rare. Conclusions: With the data from Directorate of Health in Ninawa during the period 2000-2010, lung cancer is the most common cancer but generally declining. Among all age groups, the recent incidence of lung cancer remained stable. The SCC predominance suggests change in tobacco habits as an important factor in the trends observed.

Keywords

References

  1. Abbasi S, Badheeb A (2010). Prognostic factors in advanced non-small-cell lung cancer patients: patient characteristics and type of chemotherapy. Lung Cancer Int, 2011, 152125.
  2. Al Hasnawi S, Al khuzaie A, Al Mosawi AJ, et al (2009). He Histopathological pattern of lung cancer in Iraq. N Iraqi J Med, 5, 80-3.
  3. Al-Madouj, Amal Nasser, Mr. Eldali, et al (2011). Ten year cancer incidence among Nationals of the GCC states 1998-2007, Executive Board Of Health, Ministers' Council For The Gulf, Cooperation Council State, Gulf Center for Cancer Control and Prevention, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  4. American Cancer Society (2013). Cancer facts and figures 2013.
  5. Australian Institute of Health and Welfare and Cancer Australia. (2011). Lung cancer in Australia: an overview. Cancer series no. 64. Cat. no. CAN 58. Canberra: AIHW.
  6. Canadian Cancer Society's Advisory Committee on Cancer Statistics (2013). Canadian Cancer Statistics 2013. Toronto, ON: Canadian Cancer Society.
  7. Cancer Australia (2011). Report to the Nation-Lung Cancer 2011. Cancer Australia, Sydney, NSW.
  8. Chen W, Zheng R, Zhang S, et al (2013). The incidences and mortalities of major cancers in China, 2009. Chinese J Cancer, 32, 106-12. https://doi.org/10.5732/cjc.013.10018
  9. Coleman M P, Forman D, Bryant H, et al (2011). Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet, 377, 127-38. https://doi.org/10.1016/S0140-6736(10)62231-3
  10. D'Addario G, Fruh M, Reck M, et al (2010). Metastatic nonsmall-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 21, 116-9. https://doi.org/10.1093/annonc/mdq189
  11. Demirci E, Daloglu F, Gundogdu C, et al (2012). Incidence and clinicopathologic features of primary lung cancer: a northeastern anatolia region study in Turkey (2006-2012). Asian Pac J Cancer Prev, 14, 1989-93. https://doi.org/10.7314/APJCP.2013.14.3.1989
  12. Der S, Navab R, Ishizawa K, Tsao M S (2011). Genomic and Cellular Pathology of Lung Cancer. Current Respiratory Med Rev, 7, 313-322. https://doi.org/10.2174/157339811797189740
  13. Directorate of Health in Ninawa MCMEC, (2010). Cancer In Mosul, Incidence and Mortality, Results of Mosul Center Registry; 2000-2010.
  14. El-Basmy A, Al-Mohannadi S, Al-Awadi A (2012) Some Epidemiological measures of cancer in Kuwait: National Cancer Registry Data from 2000-2009. Asian Pac J Cancer Prev, 13, 3113-8. https://doi.org/10.7314/APJCP.2012.13.7.3113
  15. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  16. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer, 49, 1374-403. https://doi.org/10.1016/j.ejca.2012.12.027
  17. Freedman LS, Edwards BK, Ries LAG, et al (2007). Cancerincidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the middle east cancer consortium (MECC) compared with US SEER. In: lung cancer: Samir Al Kayed, M. Bassam Kassem. National Cancer Institute. NIH Pub. No. 06-5873. Bethesda, MD.
  18. Gonlugur U, Gonlugur TE, Kaptanoglu M, Nadir, A, Cinar Z (2008). The changing epidemiological trends for carcinoma of the lung in Turkey. Saudi Med J, 29, 749.
  19. Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007). Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist, 12, 20-37. https://doi.org/10.1634/theoncologist.12-1-20
  20. Hippisley-Cox J, Coupland C (2011). Identifying patients with suspected lung cancer in primary care: derivation and validation of an algorithm. Brit J Gen Pract, 61, 715. https://doi.org/10.3399/bjgp11X606627
  21. Hsu CL, Chen KY, Shih JY, et al (2012). Advanced non-small cell Muzahem Mohammed Yahya AL-Hashimi and Xiang Jun Wang lung cancer in patients aged 45 years or younger: outcomes and prognostic factors. BMC Cancer, 12, 241. https://doi.org/10.1186/1471-2407-12-241
  22. Ignatius TS, Tse LA, Qiu H (2012). Occupational Lung Cancer. In A Clinical Guide to Occupational and Environmental Lung Diseases (251-264). Humana Press.
  23. International Agency for Research on Cancer, lung cancer statistics (2008).
  24. Iraqi Cancer Board (2010). Results of the Iraqi Cancer Registry 2010. Baghdad, Iraqi Cancer Registry Center, Ministry of Health.
  25. Jemal A, Siegel R, Ward E, et al, (2009). Cancer statistics. CA Cancer J Clin, 59, 225-49. https://doi.org/10.3322/caac.20006
  26. Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300. https://doi.org/10.3322/caac.20073
  27. Johnson F, Johnson FW (2009). Arrowhead Ripper: Adaptive Leadership in Full Spectrum Operations. Strategic Studies Institute.
  28. Khuder SA (2001). Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer, 31, 139-48. https://doi.org/10.1016/S0169-5002(00)00181-1
  29. Ma HT, Sriyam S, Sinchaikul S, Tsai H Y, Phutrakul S (2013). Proteomics Characterization of Haptoglobin Alpha-2 Subunit in Non-Small Cell Lung Cancer Serum and Various Human Materials. J Proteomics Bioinform, 6, 187-96.
  30. Mehrabani D, Tabei SZ, Heydari ST, et al (2008). Cancer occurrence in Fars Province, Southern Iran. Iranian Red Crescent Med J, 10, 314-22.
  31. Ministry of Planning, Central Organization for Statistics. (2012). Annual Abstract of Statistics, 2000-2009. Baghdad, Iraq.
  32. Missaoui N, Hmissa S, Landolsi H, et al (2011). Lung cancer in central Tunisia: epidemiology and clinicopathological features. Asian Pac J Cancer Prev, 12, 2305-9.
  33. Perez-Moreno P, Brambilla E, Thomas R, Soria J C (2012). Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities. Clin Cancer Res, 18, 2443-2451. https://doi.org/10.1158/1078-0432.CCR-11-2370
  34. Ramalingam SS, Owonikoko TK, Khuri FR (2011). Lung cancer: new biological insights and recent therapeutic advances. CA: A Cancer J Clin, 61, 91-112. https://doi.org/10.3322/caac.20102
  35. Salim EI, Jazieh AR, Moore MA (2011). Lung cancer incidence in the Arab league countries: Risk factors and control. Asian Pac J Cancer Prev, 12, 17-34.
  36. Sadraei NH, Taghi Riahi MD (2013). Idiopathic pulmonary fibrosis in a referral center in Iran: Are patients developing the disease at a younger age? Arch Iranian Med, 16, 177.
  37. SEER (2013). SEER Stat Fact Sheets: Lung and Bronchus
  38. Tarawneh M, Nimri O, Arkoob K, Zaghal M A (2009). Cancer Incidence in Jordan 2009. Non-Communicable Diseases Directorate, Jordan Cancer Registry. Ministry of Health.
  39. Tarrahi MJ, Mehrabani D, Khademolhosseini F, et al (2009). Lung cancer occurrence in Southern Iran. J Res Med Sci, 14, 139-40.
  40. Tas F, Keskin S (2012). Age-specific incidence ratios of lung cancer (LC) in Turkey: LC in older people is increasing. Arch Gerontol Geriatrics, 55, 276-8. https://doi.org/10.1016/j.archger.2011.09.001
  41. Tazi MA, Er-Raki A, Benjaafar N (2013). Cancer incidence in Rabat, Morocco: 2006-2008. E Cancer Med Sci, 7, 338.
  42. Yousefi-Koma A, Panah-Moghaddam M, Kalff V (2013). The utility of metabolic imaging by 18F-FDG PET/CT in lung cancer: impact on diagnosis and staging. TANAFFOS-J Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis, 12, 16-25.
  43. Zeng H, Zheng R, Zhang S, He J, Chen W (2013). Lung cancer incidence and mortality in China, 2008. Thoracic Cancer, 4, 53-8. https://doi.org/10.1111/j.1759-7714.2012.00160.x

Cited by

  1. Phase II Study on Dose Escalating Schedule of Paclitaxel Concurrent with Radiotherapy in Treating Patients with Locally Advanced Non-small Cell Lung Cancer vol.15, pp.4, 2014, https://doi.org/10.7314/APJCP.2014.15.4.1699
  2. Targeted Efficacy of Dihydroartemisinin for Translationally Controlled Protein Expression in a Lung Cancer Model vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2511
  3. Expression and Prognostic Roles of TRPV5 and TRPV6 in Non-Small Cell Lung Cancer after Curative Resection vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2559
  4. What is the Most Suitable Time Period to Assess the Time Trends in Cancer Incidence Rates to Make Valid Predictions - an Empirical Approach vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3097
  5. Secular trend analysis of lung cancer incidence in Sihui city, China between 1987 and 2011 vol.34, pp.3, 2015, https://doi.org/10.1186/s40880-015-0037-3
  6. The use of a multiple imputation method to investigate the trends in Histologic types of lung cancer in Songkhla province, Thailand, 1989–2013 vol.16, pp.1, 2016, https://doi.org/10.1186/s12885-016-2441-8
  7. Tobacco Smoking, Lung Cancer, and Therapy in Iraq: Current Perspective vol.6, pp.2296-2565, 2018, https://doi.org/10.3389/fpubh.2018.00311